Literature DB >> 12877932

Reversal of multidrug resistance in cancer cells by pyranocoumarins isolated from Radix Peucedani.

Jimmy Yiu-Cheong Wu1, Wang-Fun Fong, Jin-Xia Zhang, Chung-Hang Leung, Hoi-Lung Kwong, Meng-Su Yang, Ding Li, Hon-Yeung Cheung.   

Abstract

The pyranocoumarins, (+/-)-3'-angeloyl-4'-acetoxy-cis-khellactone, were isolated from Radix Peucedani, the dry root of Peucedanum praeruptorum Dunn, through bioassay-guided fractionation. The chemical structure of pyranocoumarins was determined by mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy. X-ray crystallography showed that there are eight molecules (i.e. two each of four conformers) in each unit cell with their optical activities equally cancelled out. The four conformers are 3'(R)-angeloyl-4'(R)-acetoxy-khellactone in two conformational forms, and 3'(S)-angeloyl-4'(S)-acetoxy-khellactone in two conformational forms. Pyranocoumarins caused apoptotic cell death with IC50 of 41.9+/-2.8 and 17.3+/-8.2 microM for drug-sensitive KB-3-1 and multidrug resistant (MDR) KB-V1, respectively. The two- to threefold sensitivity difference between the two cell lines is interesting considering that the same ratio for doxorubicin is 50-300. Strong synergistic interactions were demonstrated when pyranocoumarins were combined with common anti-tumor drugs including doxorubicin, paclitaxel, puromycin or vincristine in MDR KB-V1 cell line, but not in drug-sensitive KB-3-1 cells. Pyranocoumarins increased doxorubicin accumulation in KB-V1 cells by about 25% after 6 h of incubation. Pyranocoumarins treatment for 24 h down-regulated the expression of P-glycoprotein in KB-V1 cells at both protein and mRNA levels. Pyranocoumarins also transiently reduced the cellular ATP contents in KB-V1 cells in a dose-dependent manner. Our results suggest that pyranocoumarins could be a potential MDR reversing agent.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12877932     DOI: 10.1016/s0014-2999(03)01946-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  31 in total

Review 1.  Effects of psoralens as anti-tumoral agents in breast cancer cells.

Authors:  Maria Luisa Panno; Francesca Giordano
Journal:  World J Clin Oncol       Date:  2014-08-10

2.  Crystal structures of two 4H-chromene derivatives: 2-amino-3-cyano-4-(3,4-di-chloro-phen-yl)-7-hy-droxy-4H-benzo[1,2-b]pyran 1,4-dioxane monosolvate and 2-amino-3-cyano-4-(2,6-di-chloro-phen-yl)-7-hy-droxy-4H-benzo[1,2-b]pyran.

Authors:  S Silambarasan; A Jamal Abdul Nasser; T Mohandas
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2019-09-27

3.  Pyranocoumarins isolated from Peucedanum praeruptorum Dunn suppress lipopolysaccharide-induced inflammatory response in murine macrophages through inhibition of NF-κB and STAT3 activation.

Authors:  Peng-Jiu Yu; Hong Jin; Jun-Yan Zhang; Guang-Fa Wang; Jing-Rong Li; Zheng-Guang Zhu; Yuan-Xin Tian; Shao-Yu Wu; Wei Xu; Jia-Jie Zhang; Shu-Guang Wu
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

4.  Antitumor agents 286. Design, synthesis, and structure-activity relationships of 3'R,4'R-disubstituted-2',2'-dimethyldihydropyrano[2,3-f]chromone (DSP) analogues as potent chemosensitizers to overcome multidrug resistance.

Authors:  Ting Zhou; Qian Shi; Kenneth F Bastow; Kuo-Hsiung Lee
Journal:  J Med Chem       Date:  2010-11-17       Impact factor: 7.446

5.  Synergistic effect of bromocriptine and tumor necrosis factor-alpha on reversing hepatocellular carcinoma multidrug resistance in nude mouse MDR1 model of liver neoplasm.

Authors:  Lei Ding; Xiao-Ping Chen; Zhi-Wei Zhang; Jian Guan; Wan-Guang Zhang; Hai-Ping Wang; Zhi-Hui Wang; Chun-Lei Li
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

Review 6.  Is resistance useless? Multidrug resistance and collateral sensitivity.

Authors:  Matthew D Hall; Misty D Handley; Michael M Gottesman
Journal:  Trends Pharmacol Sci       Date:  2009-09-15       Impact factor: 14.819

7.  Bromocriptine enhances the uptake of (99m)Tc-MIBI in patients with hepatocellular carcinoma.

Authors:  Xiangting Chai; Qiaoyu Liu; Wenyu Shao; Feng Zhang; Xuehao Wang; Hai Wang
Journal:  J Biomed Res       Date:  2012-04-12

Review 8.  Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy.

Authors:  Chung-Pu Wu; Shinobu Ohnuma; Suresh V Ambudkar
Journal:  Curr Pharm Biotechnol       Date:  2011-04       Impact factor: 2.837

9.  Identification and functional characterization of a p-coumaroyl CoA 2'-hydroxylase involved in the biosynthesis of coumarin skeleton from Peucedanum praeruptorum Dunn.

Authors:  Ruolan Yao; Yucheng Zhao; Tingting Liu; Chuanlong Huang; Sheng Xu; Ziwei Sui; Jun Luo; Lingyi Kong
Journal:  Plant Mol Biol       Date:  2017-08-18       Impact factor: 4.076

10.  (Z)-3-(1-Hy-droxy-3-oxobut-1-en-yl)-6-nitro-2H-chromen-2-one.

Authors:  Nishith Saurav Topno; Venkataswamy Tangeti; H Surya Prakash Rao; R Krishna
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.